Enrollment completed ahead of schedule in the first dose expansion cohortMomentum continues with first patient dosed in the second expansion cohortTopline results from the 40-patient dose expansion st ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novo Nordisk (NVO – Research Report) and Veeva Systems (VEEV ...

Bayer AG BAYRY reported fourth-quarter 2024 core earnings of 28 cents per American Depositary Receipt (ADR), in line with the ...

Novartis ADR earns the No. 1 rank among its peers in the Medical-Ethical Drugs industry group. Phibro Animal Health and Jazz ...

FDA-approved product in a multi-billion-dollar market Revenue generation projected in 2025 EDINBURGH, Scotland, March 5, 2025 /PRNewswire/ -- TC BioPharm (Holdings) ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and autoimmune diseases, today announced that Ipsen (Euronext: ...

Detailed price information for Anheuser-Busch Inbev S.A. ADR (BUD-N) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...

The Pharmacovigilance Programme of India (“PvPI”) is the primary, drug safety monitoring programme in India which collects, ...